Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation

Sirolimus is an effective agent used in graft-versus-host disease (GVHD) prophylaxis after allogeneic transplantation. It also has antiproliferative effects on vascular endothelium when used to coat coronary artery stents. We noted an excess of veno-occlusive disease (VOD) in a clinical trial, and r...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Cutler, Corey, Stevenson, Kristen, Kim, Haesook T., Richardson, Paul, Ho, Vincent T., Linden, Erica, Revta, Carolyn, Ebert, Ruth, Warren, Diane, Choi, Sung, Koreth, John, Armand, Philippe, Alyea, Edwin, Carter, Shelly, Horowitz, Mary, Antin, Joseph H., Soiffer, Robert
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2008
Teme:
Clinical Trials and Observations
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2597119/
https://ncbi.nlm.nih.gov/pubmed/18776081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-07-169342
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items